Solange M T Serrano Selected Research

atrolysin C

9/2006

Structural features of the reprolysin atrolysin C and tissue inhibitors of metalloproteinases (TIMPs) interaction.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Solange M T Serrano Research Topics

Disease

13	Hemorrhage 10/2021 - 06/2005
6	Inflammation (Inflammations) 10/2021 - 09/2004
6	Snake Bites (Snake Bite) 01/2020 - 04/2011
4	Melanoma (Melanoma, Malignant) 10/2021 - 01/2018
4	Necrosis 01/2019 - 06/2005
3	Neoplasms (Cancer) 10/2021 - 01/2018
2	Edema (Dropsy) 01/2020 - 06/2005
2	Carcinogenesis 10/2019 - 01/2018
2	Infections 01/2018 - 11/2011
2	Hypotension (Low Blood Pressure) 06/2015 - 06/2005
2	Hypertension (High Blood Pressure) 03/2012 - 07/2009
2	Autolysis 06/2009 - 02/2003
2	Poisoning 01/2007 - 03/2003
1	COVID-19 01/2022
1	Neoplasm Metastasis (Metastasis) 12/2020
1	Tissue Adhesions 01/2020
1	Bacteremia 01/2020
1	Sepsis (Septicemia) 01/2020
1	Ischemia 01/2019
1	Pathologic Processes 01/2017
1	Tachycardia (Tachyarrhythmias) 06/2015
1	Paracoccidioidomycosis (South American Blastomycosis) 10/2014
1	Leptospirosis 11/2011
1	Osteosarcoma (Osteogenic Sarcoma) 10/2005
1	Hypovolemia 06/2005

Drug/Important Bio-Agent (IBA)

16	Proteins (Proteins, Gene)FDA Link 10/2021 - 02/2003
14	Metalloproteases (Metalloproteinases)IBA 10/2021 - 02/2003
10	Snake Venoms (Snake Venom)IBA 10/2021 - 03/2003
7	VenomsIBA 06/2015 - 09/2004
4	Peptide Hydrolases (Proteases)FDA Link 10/2021 - 01/2018
4	Peptides (Polypeptides)IBA 01/2020 - 04/2011
4	Cysteine (L-Cysteine)FDA Link 06/2009 - 02/2003
3	Biological ProductsIBA 10/2021 - 10/2019
3	Laminin (Merosin)IBA 01/2020 - 11/2011
3	CollagenIBA 01/2019 - 10/2005
2	Blood Proteins (Serum Proteins)IBA 10/2021 - 01/2019
2	Fibrinogen (Factor I)FDA Link 01/2020 - 03/2014
2	Proteoglycans (Proteoglycan)IBA 01/2020 - 01/2019
2	Extracellular Matrix ProteinsIBA 10/2019 - 12/2006
2	EnzymesIBA 01/2019 - 01/2017
2	Bothrops jararaca VenomIBA 01/2019 - 09/2005
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 06/2015 - 03/2012
2	DisintegrinsIBA 06/2009 - 02/2003
1	PeptidomimeticsIBA 01/2022
1	poly(tetramethylene succinate-co-tetramethylene adipate)IBA 01/2022
1	Complement System Proteins (Complement)IBA 10/2021
1	Conditioned Culture MediaIBA 12/2020
1	ProteomeIBA 12/2020
1	estropipate (Ogen)FDA LinkGeneric 01/2020
1	antiarrhythmic peptide (AAP)IBA 01/2020
1	matrigelIBA 01/2020
1	Fibrinolysin FDA Link 01/2020
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2019
1	Viper Venoms (Viper Venom)IBA 01/2019
1	IsotopesIBA 01/2019
1	Antivenins (Antivenoms)IBA 01/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017
1	Proline (L-Proline)FDA Link 06/2015
1	OligopeptidesIBA 06/2015
1	Virulence Factors (Pathogenicity Factors)IBA 10/2014
1	BradykininIBA 03/2012
1	Captopril (Capoten)FDA LinkGeneric 03/2012
1	PlasminogenIBA 11/2011
1	AntibodiesIBA 11/2011
1	Antihypertensive Agents (Antihypertensives)IBA 07/2009
1	PoisonsIBA 01/2007
1	Therapeutic UsesIBA 01/2007
1	Membrane Proteins (Integral Membrane Proteins)IBA 09/2006
1	atrolysin CIBA 09/2006
1	atrolysin AIBA 10/2005
1	Integrin alpha2beta1IBA 10/2005
1	von Willebrand FactorIBA 10/2005
1	Interleukin-1beta (Interleukin 1 beta)IBA 09/2005
1	Interleukin-6 (Interleukin 6)IBA 09/2005
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2005
1	Interleukin-8 (Interleukin 8)IBA 09/2005
1	Macrophage-1 Antigen (Macrophage 1 Antigen)IBA 09/2004

Therapy/Procedure

1	Therapeutics 07/2009
1	Lasers (Laser) 09/2005